Tech Company Inital Public Offerings
Tengion IPO
Headquartered in Winston-Salem, Tengion is now a public company.
Transaction Overview
Company Name
Announced On
4/12/2010
Transaction Type
IPO
Amount
$30,000,000
Proceeds Purpose
Proceeds purposes are detailed in the Company's statements on file with the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3929 Westpoint Blvd. G
Winston-Salem, NC 27103
USA
Winston-Salem, NC 27103
USA
Phone
Website
Email Address
Overview
Tengion (NASDAQ: TNGN) is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient's own (autologous) cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Miclot
Chief Financial Officer
Brian Davis
Chief Scientific Officer
Tim Bertram
Chief Technical Officer
Deepak Jain
Browse more venture capital transactions:
Prev: 4/12/2010: Carmot Therapeutics venture capital transaction
Next: 4/13/2010: Qcept Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs